Microbiology, Clinical Profile and Outcomes of Continuous Ambulatory Peritoneal Dialysis associated Peritonitis
DOI:
https://doi.org/10.59779/jiomnepal.1353Keywords:
Continuous ambulatory, Microbiology, Outcome, PeritonitisAbstract
Introduction
CAPD associated peritonitis is a common complication associated with high morbidity and mortality. Clinical data regarding peritonitis is scarce in our population. In this study, we aimed to determine the microbiology, clinical profile and outcomes of peritonitis in CAPD patients at a tertiary referral center in Nepal.
Methods
A retrospective, observational study was conducted at a tertiary care center in Kathmandu over a period of two years from August, 2022 to July 2024. Data on demographics, clinical presentation, organisms isolated, treatment and outcomes were retrieved. Statistical analysis was done by using SPSS v26. The categorical data and continuous data were analyzed using mean, standard deviation and percentage.
Results
There were 20 episodes of peritonitis in 17 patients. There were eight male patients. Mean age of the patients was 48.45± 9.6 years. Sixteen were culture positive (80%). Peritonitis due to gram-negative organisms 10 (62.5%) was higher. The most common organisms isolated were Pseudomonas aeruginosa (4) followed by Escherichia coli (2), Klebsiella sp. (2), Staphylococcus aureues (2), coagulase negative Staphylococcus (2) and Enterococcus sp. (2). The most common clinical presentation was abdominal pain. Fifteen percent episodes were constituted by refractory, recurrent and repeat peritonitis. Outcomes were recovery (95%), catheter removal and switch to hemodialysis (5%). There were no deaths due to peritonitis in the study population.
Conclusion
CAPD peritonitis due to Gram-negative organisms was more frequent than that due to gram-positive organisms in our CAPD population. Most of the patients of CAPD recovered.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Journal of Institute of Medicine Nepal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.












